Jump to content

Draft:Micro Labs Limited

From Wikipedia, the free encyclopedia
Micro Labs Limited
Company typePrivate
IndustryPharmaceuticals
Founded1973
FounderG. C. Surana
Headquarters
Bengaluru, Karnataka
Area served
Worldwide
Key people
G. C. Surana (Founder)
Dilip Surana (Chairman and Managing Director)
Anand Surana (Joint Managing Director)
ProductsGeneric drugs, branded formulations, active pharmaceutical ingredients
Revenue₹5,300 crore (2023, approx.)
Number of employees
10,000+
Websitemicrolabsltd.com

Micro Labs Limited is an Indian pharmaceutical company headquartered in Bengaluru, Karnataka. It was founded in 1973 by G. C. Surana and is currently managed by his sons Dilip Surana and Anand Surana. The company manufactures generic and branded formulations as well as active pharmaceutical ingredients (APIs), and exports to more than 50 countries.[1][2][3]

History

[edit]

Micro Labs began operations in 1973. Over time, it expanded its product portfolio to include medicines in therapeutic areas such as cardiology, diabetology, anti-infectives, and pain management. By the 2000s, it had established multiple facilities across India for both domestic and international supply.[4][5][6]

Products

[edit]

The company manufactures a wide range of pharmaceuticals, including antibiotics, cardiovascular and antidiabetic drugs, and analgesics. Its most widely known brand is Dolo-650, a paracetamol formulation that saw extensive demand in India during the COVID-19 pandemic.[7][8][9]

Operations

[edit]

Micro Labs operates more than 20 manufacturing facilities in states including Karnataka, Goa, Kerala, and Sikkim. These are certified for Good Manufacturing Practices (GMP) and cater to both domestic and regulated international markets. The company employs over 10,000 people.[10][11][12]

Financials

[edit]

As of the fiscal year ending 31 March 2024, Micro Labs Limited, the manufacturer of Dolo 650, reported revenues of approximately ₹6,670 crore.[13]In the previous year, credit rating agency CRISIL noted that the company’s revenue for FY 2023 was around ₹5,300 crore, driven by both domestic formulations and export growth.[14]

According to EMIS, the company has recorded consistent increases in key indicators such as operating profit, EBITDA, net profit, total assets, and equity in recent years.[15]The company also states in its corporate presentation that nearly 10 % of its revenue is derived from its Contract Research and Manufacturing Services (CRAMS) business.[16]

Controversies

[edit]

In July 2022, the Income Tax Department conducted searches at Micro Labs' offices and promoters' residences across several states. Authorities alleged tax evasion of over ₹300 crore and the distribution of freebies to doctors valued at around ₹1,000 crore, practices which were considered violations of tax and ethical norms.[17][18][19]

See also

[edit]

References

[edit]
  1. ^ FE Online (25 September 2023). "Meet Dilip Surana: The man who earned Rs 400 crore selling Dolo; take a look inside his Rs 66 crore house". The Financial Express. The Indian Express Group. Retrieved 1 October 2025.
  2. ^ McClatchie, Chrissie (19 January 2021). "Dilip Surana, Chairman and Managing Director of Micro Labs". The CEO Magazine. Retrieved 1 October 2025.
  3. ^ "Shri Dilip Surana". JATF. Retrieved 1 October 2025.
  4. ^ FE Online (25 September 2023). "Meet Dilip Surana: The man who earned Rs 400 crore selling Dolo; take a look inside his Rs 66 crore house". The Financial Express. The Indian Express Group. Retrieved 1 October 2025.
  5. ^ McClatchie, Chrissie (19 January 2021). "Dilip Surana, Chairman and Managing Director of Micro Labs". The CEO Magazine. Retrieved 1 October 2025.
  6. ^ "Shri Dilip Surana". JATF. Retrieved 1 October 2025.
  7. ^ FE Online (25 September 2023). "Meet Dilip Surana: The man who earned Rs 400 crore selling Dolo; take a look inside his Rs 66 crore house". The Financial Express. The Indian Express Group. Retrieved 1 October 2025.
  8. ^ McClatchie, Chrissie (19 January 2021). "Dilip Surana, Chairman and Managing Director of Micro Labs". The CEO Magazine. Retrieved 1 October 2025.
  9. ^ "Shri Dilip Surana". JATF. Retrieved 1 October 2025.
  10. ^ FE Online (25 September 2023). "Meet Dilip Surana: The man who earned Rs 400 crore selling Dolo; take a look inside his Rs 66 crore house". The Financial Express. The Indian Express Group. Retrieved 1 October 2025.
  11. ^ McClatchie, Chrissie (19 January 2021). "Dilip Surana, Chairman and Managing Director of Micro Labs". The CEO Magazine. Retrieved 1 October 2025.
  12. ^ "Shri Dilip Surana". JATF. Retrieved 1 October 2025.
  13. ^ "Micro Labs Limited – 2025 Financials". Tracxn. 11 July 2025. Retrieved 1 October 2025.
  14. ^ "Micro Labs Limited – Rating Rationale". CRISIL. 24 April 2025. Retrieved 1 October 2025.
  15. ^ "Micro Labs Limited Company Profile". EMIS. Retrieved 1 October 2025.
  16. ^ "Micro Labs GmbH – Company Presentation" (PDF). Micro Labs GmbH. Retrieved 1 October 2025.
  17. ^ FE Online (25 September 2023). "Meet Dilip Surana: The man who earned Rs 400 crore selling Dolo; take a look inside his Rs 66 crore house". The Financial Express. The Indian Express Group. Retrieved 1 October 2025.
  18. ^ McClatchie, Chrissie (19 January 2021). "Dilip Surana, Chairman and Managing Director of Micro Labs". The CEO Magazine. Retrieved 1 October 2025.
  19. ^ "Shri Dilip Surana". JATF. Retrieved 1 October 2025.
[edit]
This page will be placed in the following categories if it is moved to the article namespace.
Categories:

Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Micro_Labs_Limited&oldid=1314944418"